Hints and tips:
Related Special Reports
...The Centers for Medicare & Medicaid Services said last month that Medicare Part D drug benefit plans will cover weight loss medicines when they are approved to treat a separate medical problem, such as heart...
...Member states received a new draft of the text from the World Health Organization late on Friday, with the last round of talks set to take place at the end of March....
...But officials warn that the May deadline for adoption of the treaty will be missed if poorer and richer countries cannot bridge significant divisions over a vital article, the Pathogen Access and Benefit-Sharing...
...It spent $1.6tn on Medicare and Medicaid healthcare benefits in 2021 — or more than a third of total healthcare spending. To contain spiralling costs, the US has pushed for more value-based care....
...Its platform streamlines access to private programmes and government benefits such as Medicaid, a US government health insurance programme for people on low incomes....
...The final negotiations will be a test of whether countries can set aside gripes and in some cases widening divisions....
...Robert Andrews, chief executive of the HTA, said it was “almost impossible to overstate the financial and health impact” of the drugs, given that chronic diseases driven by obesity were a major source of...
...This, says Calvert’s Pryce, is why it is important to ensure that “profit” is measured in terms of the benefits to the next generation’s health and wellbeing....
...Steve Barclay, the UK health and social care secretary, hailed Mounjaro’s potential to help cut waiting lists and save the National Health Service “billions of pounds”....
...Moreover, it affects health in almost every way, from cognitive function to bone strength. “Going through menopause is the worst thing that can happen to a woman in terms of her health,” Garrison says....
...It reported an annual operating profit of £1.5bn, slightly ahead of expectations. Private health sales rose 41 per cent in 2023, as Aviva continued to benefit from strains on public healthcare....
...The technology promises benefits in planning for situations with predictable starting points, such as corners. The wider task is to apply it to the richer variability of open play....
...Teresa Graham, chief of Roche’s pharmaceutical division, said more patients suffered from diseases of the immune system than from cancer, and the current drugs did not serve them well....
...As such, the relative spread between refined product prices and the value of crude oil inputs (refining margin) can indicate the health of global economic activity....
...Negotiations on the new agreement began after Easter and are due to conclude by the end of the year. The Department of Health and Social Care did not immediately respond to a request for comment....
...The drug will have a US list price of $26,500 a year, although health insurers will negotiate that down....
...It has built up a large pharmacy benefit management business and a leading health insurance division via acquisitions. Wentworth used to run pharmacy benefit manager (PBM) Express Scripts....
...James Gelfand, president of the ERISA Industry Committee, which represents large US employers that provide health benefits, says the conflict is taking over his LinkedIn feed....
...The advent of “value-based” care under the US’s state Medicare and Medicaid systems is triggering a gold rush among insurers, healthcare providers and benefits managers....
...Until then, she’d managed her health with a combination of drugs and other therapies, which constantly sent her in and out of hospital....
...The process is due to begin in earnest in September when the Centers for Medicare & Medicaid Services (CMS) is due to identify 10 expensive drugs that will be the focus of the negotiation....
...The US federal government is the top customer, providing $1.6tn on Medicare and Medicaid healthcare benefits in 2021 — or more than a third of the total....
...Divisions between rich and poor countries on the sharing of genomic data on pathogens and funding for health systems during emergencies are threatening progress on a global pandemic treaty....
...However, investors will be getting increasingly nervous about the underlying health of the language services group, which translates things like patents and technical documents....
...In the wake of the controversy over the FDA approval of Biogen’s aducanumab, the US Centers for Medicare and Medicaid Services said only patients taking part in a clinical trial would benefit from reimbursement...
International Edition